| Originator Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Phase 1 | China  | 30 Nov 2022 | |
| Neoplasms | Phase 1 | China  | 30 Nov 2022 | 





